UNSPSC 51383905: Lysine clonixinate

This classification denotes a non-morphinic analgesic with the molecular formula C13H11ClN2O2.C6H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06PW4M190R, chemically known as 3-pyridinecarboxylic acid, 2-((3-chloro-2-methylphenyl)amino)-, compd. with l-lysine (1:1) but generally known as lysine clonixinate, which bears US NIH Compound Identifier 3080836. European Medicines Agency schedules Lysine clonixinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01363MIG.

SMILES: CC1=C(C=CC=C1Cl)NC2=C(C=CC=N2)C(=O)O.C(CCN)CC(C(=O)O)N.

UNSPSC 51383905 Lysine clonixinate is a Commodity code that encompasses pharmaceutical products, though recent state and local procurement activity under this code shows minimal alignment with the nominal scope. Seminole County, Florida's recent IFB (Invitation for Bid) solicitation was tagged to this code but actually seeks Naloxone and Safe Drug Deactivation Systems—opioid-reversal medications and harm-reduction equipment rather than lysine clonixinate, an anti-inflammatory analgesic. The mismatch suggests either a tagging error in the county's e-Procurement Portal or a broader categorization practice that does not reflect the specific pharmaceutical product the code nominally represents. State and local buyers appear to use this code infrequently or inconsistently for pharmaceutical procurement.

The single recent opportunity on record is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, calling for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year term with one-year renewal option. Deliveries are quarterly to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, hold required insurance coverage including workers' compensation and commercial general liability, obtain E-Verify certification, and comply with federal regulations if FEMA funds the contract. The code shows little demonstrable recent activity relevant to lysine clonixinate procurement across state and local jurisdictions.